Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tafamidis
tafamidis
Pfizer's rare heart disease drug succeeds in late-stage study
Yahoo/Reuters
Fri, 03/30/18 - 09:35 am
Pfizer
clinical trials
tafamidis
transthyretin cardiomyopathy
rare disease
Alnylam
Ionis Pharmaceuticals
Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease
Yahoo
Mon, 08/8/16 - 09:57 am
Pfizer
Vyndaqel
tafamidis
TTR-FAP
The Meaningless Drug Approval That Could Cost the Industry Billions
Motley Fool
Mon, 05/28/12 - 11:16 am
drug approvals
Pfizer
tafamidis
familial amyloid polyneuropathy
FDA Panel Sends Mixed Message About Pfizer Drug
Pharmalot
Fri, 05/25/12 - 11:19 am
FDA
advisory panel
Pfizer
tafamidis
familial amyloid polyneuropathy
Pfizer, FoldRx drug extends survival
Fierce Biotech
Wed, 04/13/11 - 10:52 am
Pfizer
FoldRx
tafamidis
TTR-FAP
Pfizer receives 'refuse to file' letter from FDA for compound tafamidis
Yahoo/AP
Mon, 04/4/11 - 09:06 am
FDA
tafamidis
Pfizer
transthyretin familial amyloid polyneuropathy
FoldRx banks $29M for neurodegenerative drug application
Fierce Biotech
Tue, 06/15/10 - 10:51 am
FoldRx
financing
tafamidis
Pages
« first
‹ previous
1
2